| Date | Title | Description | Source |
| 26.03.2024 | Recipharm attains major sustainability milestones | Recipharm attains major sustainability milestones
Tue, Mar 26, 2024 09:00 CET Report this content
Ap... | news.cisio... |
| 13.03.2024 | ReciBioPharm and GeneVentiv Therapeutics partner to advance ... | ReciBioPharm and GeneVentiv Therapeutics partner to advance first AAV-based gene therapy for haemoph... | news.cisio... |
| 13.03.2024 | $69.7 Billion Oral Solid Dosage Contract Manufacturing Marke... | - | globenewsw... |
| 13.03.2024 | Global Oral Solid Dosage Contract Manufacturing Market 2024-... | - | globenewsw... |
| 23.01.2024 | Recipharm, Medspray, and Resyca enter into exclusive license... | Recipharm, Medspray, and Resyca enter into exclusive license agreement to develop nasally-delivered ... | news.cisio... |
| 19.12.2023 | Recipharm Harmonizes its Global Quality Operations with Veev... | Leading CDMO adopts Veeva Vault QMS, Vault QualityDocs, and Vault Training to standardize quality pr... | aithority.... |
| 19.12.2023 | Recipharm harmonizes its global quality operations with Veev... | Recipharm harmonizes its global quality operations with Veeva Vault Quality
Tue, Dec 19, 2023 13:05 ... | news.cisio... |
| 11.12.2023 | ReciBioPharm partners with Acuitas Therapeutics to provide r... | ReciBioPharm partners with Acuitas Therapeutics to provide rapid technology transfers and CGMP manuf... | news.cisio... |
| 05.12.2023 | Recipharm announces collaboration with Oz-UK to accelerate t... | Recipharm announces collaboration with Oz-UK to accelerate the development of low global warming pot... | news.cisio... |
| 05.09.2023 | Recipharm partners with Ahead Therapeutics to develop rare a... | Recipharm partners with Ahead Therapeutics to develop rare autoimmune disease therapy
Tue, Sep 05, 2... | news.cisio... |
| 23.08.2023 | Recipharm makes senior appointments as transition to low glo... | Recipharm makes senior appointments as transition to low global warming potential propellants in pre... | news.cisio... |
| 17.08.2023 | Recipharm and Honeywell to speed development of inhalers wit... | Recipharm and Honeywell to speed development of inhalers with a near-zero global warming potential p... | news.cisio... |
| 11.07.2023 | Recipharm’s new analytical lab brings impressive testing cap... | Recipharm’s new analytical lab brings impressive testing capabilities to global markets
Tue, Jul 11,... | news.cisio... |
| 11.05.2023 | NewBiologix launches with $50M to make gene therapies more v... | | startuptic... |
| 02.05.2023 | FDA approves the manufacture of new microbiome-based therape... | FDA approves the manufacture of new microbiome-based therapeutic VOWST™ at Recipharm site
Tue, May 0... | news.cisio... |
| 28.04.2023 | Arranta Bio, a Recipharm company, signs contract with MIT to... | Arranta Bio, a Recipharm company, signs contract with MIT to develop rapid manufacturing of mRNA the... | news.cisio... |
| 04.04.2023 | Recipharm bolsters senior leadership team with appointment o... | Recipharm bolsters senior leadership team with appointment of Joaquim Mascaro as Chief Financial Off... | news.cisio... |
| 16.03.2023 | Stevanato Group collaborates with Recipharm to develop and m... | Stevanato Group collaborates with Recipharm to develop and manufacture pre-fillable syringes for use... | news.cisio... |
| 16.03.2023 | Stevanato Group collaborates with Resyca® to develop and man... | Stevanato Group collaborates with Resyca® to develop and manufacture pre-fillable syringes for use i... | news.cisio... |
| 09.03.2023 | Recipharm’s Arranta Bio expands RNA process development capa... | Recipharm’s Arranta Bio expands RNA process development capacity by 50 per cent to meet increased cu... | news.cisio... |
| 05.12.2022 | Recipharm announces extension of commercial manufacturing to... | Recipharm announces extension of commercial manufacturing to support RedHill Biopharma’s Talicia® to... | news.cisio... |
| 30.11.2022 | Recipharm invests in its single dose nasal platform capabili... | Recipharm invests in its single dose nasal platform capabilities
Wed, Nov 30, 2022 10:00 CET Report ... | news.cisio... |
| 14.07.2022 | Transpire Bio announces agreement with Recipharm for the dev... | Transpire Bio announces agreement with Recipharm for the development of an inhaled medicine
Thu, Jul... | news.cisio... |
| 29.04.2022 | Recipharm offers services to enable switch to next generatio... | Recipharm offers services to enable switch to next generation pMDI propellants
Fri, Apr 29, 2022 08:... | news.cisio... |
| 11.04.2022 | Recipharm completes US biologics acquisitions | Recipharm completes US biologics acquisitions
Mon, Apr 11, 2022 07:00 CET Report this content
Reciph... | news.cisio... |
| 10.03.2022 | Recipharm pledges support to conflict victims | Recipharm pledges support to conflict victims
Thu, Mar 10, 2022 08:00 CET Report this content
Reciph... | news.cisio... |
| 24.02.2022 | On a roll, Recipharm wraps up its second and third CDMO acqu... | Recipharm is ending the month of February the same way it started: with an acquisition. Two of them,... | endpts.com... |
| 23.02.2022 | Recipharm invests in new high-speed filling line to meet dem... | Recipharm invests in new high-speed filling line to meet demand for aseptic products
Wed, Feb 23, 20... | news.cisio... |
| 18.02.2022 | Recipharm acquires Arranta Bio, a CDMO leader in advanced th... | Recipharm acquires Arranta Bio, a CDMO leader in advanced therapy medicinal products (ATMPs), to exp... | news.cisio... |
| 18.02.2022 | Recipharm expands its advanced therapy medicinal products (A... | Recipharm expands its advanced therapy medicinal products (ATMPs) offering into Virotherapies with t... | news.cisio... |
| 01.02.2022 | Recipharm acquires GenIbet to bolster Biologics offering | Recipharm acquires GenIbet to bolster Biologics offering
Tue, Feb 01, 2022 11:45 CET Report this con... | news.cisio... |
| 28.01.2022 | Construction works launch at new fill finish facility in Mor... | Construction works launch at new fill finish facility in Morocco Fri, Jan 28, 2022 10:00 CET
Global ... | news.cisio... |
| 27.01.2022 | Recipharm secures vaccine manufacturing deal | Recipharm secures vaccine manufacturing deal Thu, Jan 27, 2022 09:00 CET
Global contract development... | news.cisio... |
| 11.01.2022 | After a year of big investments, Recipharm sells off as... | Recipharm is having a yard sale to start the new year.
The company announced a pair of deals M... | endpts.com... |
| 11.01.2022 | Korean conglomerate SK takes out stake in cell and gene... | A Pennsylvania CDMO specializing in cell and gene therapy manufacturing is receiving ... | endpts.com... |
| 11.01.2022 | Recall report: Another month, another issue with NDM... | It’s been six months since the last incident, but 2021 ended with the tally resetting back to ... | endpts.com... |
| 11.01.2022 | Low-profile Shanghai-based CDMO secures high profile in... | In a bid to expand R&D and manufacturing capabilities, Shanghai-based ZhenGe Biotech n... | endpts.com... |
| 10.01.2022 | Pharmaron acquires commercial API manufacturing facility in ... | Pharmaron acquires commercial API manufacturing facility in the United Kingdom from Recipharm Mon, J... | news.cisio... |
| 10.01.2022 | Recipharm announces sale of Fontaine-lès-Dijon site to Astre... | Recipharm announces sale of Fontaine-lès-Dijon site to Astrea Mon, Jan 10, 2022 10:15 CET
Recipharm ... | news.cisio... |
| 24.09.2021 | First customer boards Recipharm’s soft mist inhaler technolo... | First customer boards Recipharm’s soft mist inhaler technology platform Fri, Sep 24, 2021 11:00 CET
... | news.cisio... |
| 24.08.2021 | Recipharm launches new laboratory to expand analytical servi... | Recipharm launches new laboratory to expand analytical services offering Tue, Aug 24, 2021 11:00 CET... | news.cisio... |
| 15.07.2021 | Recipharm invests in fill finish capacity | Recipharm invests in fill finish capacity Thu, Jul 15, 2021 13:00 CET
Global contract development an... | news.cisio... |
| 05.01.2021 | Moderna inks deal for overseas Covid-19 vaccine finish... | Despite a lack of formal approval from the European Medicines Agency, Moderna is moving to... | endpts.com... |
| 14.12.2020 | EQT AB (PUBL)
EQT : IX, through Roar BidCo AB, announces a ... | EQT IX[1 ]("EQT IX"), through Roar BidCo AB[2] ("Roar BidCo"), hereby announces ... | marketscre... |
| 14.12.2020 | EQT : IX, through Roar BidCo AB, announces a public offer of... | EQT IX[1 ]("EQT IX"), through Roar BidCo AB[2] ("Roar BidCo"), hereby announces ... | marketscre... |
| 14.06.2018 | Sanofi sells manufacturing site to Recipharm; Aptose ... | → Sanofi is selling off its contract respiratory drug manufacturing site in the UK to Rec... | endpts.com... |
